Advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling and up-regulation of Egr-1 in hypoxic macrophages - Wikidata - awgldk - TriplyDB

Advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling and up-regulation of Egr-1 in hypoxic macrophages

Advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling and up-regulation of Egr-1 in hypoxic macrophages

http://www.wikidata.org/entity/Q34003967

about

Identification of metabolites, clinical chemistry markers and transcripts associated with hepatotoxicity RAGE: a new frontier in chronic airways disease Serum from obstructive sleep apnea patients induces inflammatory responses in coronary artery endothelial cells The multiple faces of RAGE--opportunities for therapeutic intervention in aging and chronic disease RAGE regulates the metabolic and inflammatory response to high-fat feeding in mice Formin mDia1 mediates vascular remodeling via integration of oxidative and signal transduction pathways.Emerging Targets for Therapeutic Development in Diabetes and Its Complications: The RAGE Signaling Pathway.Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension.Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling.Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond.PKCβ promotes vascular inflammation and acceleration of atherosclerosis in diabetic ApoE null mice.Aldose reductase drives hyperacetylation of Egr-1 in hyperglycemia and consequent upregulation of proinflammatory and prothrombotic signals.Advanced glycation endproducts: from precursors to RAGE: round and round we go.HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation.AGEs, RAGE, and diabetic retinopathy.Transmission of prions within the gut and towards the central nervous system.Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications.Receptor for advanced glycation end products (RAGE) and implications for the pathophysiology of heart failure.Molecular mechanisms regulating macrophage response to hypoxia.The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes.RAGE regulation and signaling in inflammation and beyond.Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.Unlocking the biology of RAGE in diabetic microvascular complications Receptor for advanced glycation end products (RAGE) and its ligands: focus on spinal cord injury.Deoxycholic acid-modified polyethylenimine based nanocarriers for RAGE siRNA therapy in acute myocardial infarction.2016 ATVB Plenary Lecture: Receptor for Advanced Glycation Endproducts and Implications for the Pathogenesis an Treatment of Cardiometabolic Disorders: Spotlight on the Macrophage.HMGB1 enhances the protumoral activities of M2 macrophages by a RAGE-dependent mechanism.Glycation & the RAGE axis: targeting signal transduction through DIAPH1.RAGE-TLR Crosstalk Sustains Chronic Inflammation in Neurodegeneration.Hypoxia driven glycation: Mechanisms and therapeutic opportunities.Impaired slow axonal transport in diabetic peripheral nerve is independent of RAGE.The AGE-RAGE Axis: Implications for Age-Associated Arterial Diseases.Relationship between serum levels of endogenous secretory RAGE and blood pressure in male nondiabetic patients with obstructive sleep apnea.Serum advanced glycation end products are associated with insulin resistance in male nondiabetic patients with obstructive sleep apnea.REC8 inhibits EMT by downregulating EGR1 in gastric cancer cells.The Formin, DIAPH1, is a Key Modulator of Myocardial Ischemia/Reperfusion Injury.RAGE signaling by alveolar macrophages influences tobacco smoke-induced inflammation.Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney Disease.N-myc downstream-regulated gene 1 is involved in the regulation of cystogenesis in transgenic mice overexpressing human PKD2 gene.Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson’s Disease.

P2860

Q21089700-1D887EE7-25DD-4F24-A1FB-85A7D2141B35 Q27025295-0A00BBA5-D8A6-4386-B552-D989FF453C36 Q28393387-8FB881DD-14C5-416D-9EFD-88EFA57D67E2 Q28830568-C0359987-C9A5-426B-AD00-BB01C98855E3 Q33646761-A66C2DE4-68ED-4B6D-8998-7147F554D683 Q36054820-456EBB91-4B47-4D45-BB59-E265C17B2620 Q36207823-AC7CC74D-A197-4007-BC9A-B17C11F771FC Q36340848-02CD66DD-D30A-493B-B8B5-AE78A6B4D189 Q36478250-E708F3FC-5C4A-4899-AAED-38BE24518759 Q37291206-F1C8C0D5-FE16-4B57-8356-9EA884C45863 Q37397476-D110F2C4-CDCF-430E-8036-3166EDD2A1B3 Q37510157-9E51EF84-1E8E-4494-AD67-6BAEC7BEBBE9 Q37801314-6D6C74A2-D74E-4F44-8475-7E21CE08B321 Q37876420-CC0D39E5-F80E-4B86-90CB-4392E66B1811 Q37876790-FACEC4A5-C642-43A8-9CF4-66F367C8C6F2 Q37911181-D2EF3A54-C1BA-4A20-837F-210FF6A3C591 Q37972674-85A85A96-61F0-424C-BE28-F42A4643DB7C Q37997993-50A8289D-2206-4140-B4A0-FC3DFB76D67F Q38008339-7FD3C5DA-3EB0-4C94-8B14-858F344216FA Q38023062-0279B184-A429-440B-A7A5-27F089ACCD4F Q38094691-995E7FD7-02D7-4A40-B016-46C9949435D7 Q38096444-E458B7D9-48E0-450D-A020-D3784DE83196 Q38134924-7A1F667A-12C2-4FC3-A9F0-8EB454563586 Q38234624-26549691-CB86-4B88-85A8-FD4C8DF98770 Q38430098-547E5949-C35B-4712-857B-8E7C16976D67 Q38759194-6D85A847-7542-4F93-ABC3-CD6940BBDD53 Q38830051-85275916-60A2-4EA3-B9BA-D02EF9DAD697 Q39038218-0FAEBB30-D48B-4A36-8DBE-E30A011A4655 Q39123617-149EE35D-B1FB-4004-9098-E3C02AF8A09D Q39331191-7884711F-CAB9-4C2B-B056-A4C033D02AE9 Q45893258-034412F3-C25E-4C93-942F-22000BC2FD5C Q47094524-A5B2977E-ACB0-47C5-8548-8E3FFA325FA1 Q47971641-A1D0A2A1-8741-49CC-9BB2-4A5D3D3C2FFD Q48003122-E8C9AC35-34D6-4400-A692-14B85C917A1D Q49378805-F2A5C1FD-1320-4192-8C3D-29DB71DB7CD0 Q49844367-6BE446EA-AFD5-4980-9696-F6C3D9F5BCC8 Q51793428-27C0BAD1-02B7-43E2-895D-396376C7DCE4 Q52680904-70773470-A6D4-42AA-997A-63F71C49DCC2 Q53130916-C88200F4-0525-462D-A107-77ABD649B752 Q55226753-71C8E6CB-B53E-4AEF-9B54-253678FB1FC1

P2860

Advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling and up-regulation of Egr-1 in hypoxic macrophages

http://www.wikidata.org/entity/Q34003967

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Advanced glycation end product ...... f Egr-1 in hypoxic macrophages

@ast

Advanced glycation end product ...... f Egr-1 in hypoxic macrophages

@en

type

label

Advanced glycation end product ...... f Egr-1 in hypoxic macrophages

@ast

Advanced glycation end product ...... f Egr-1 in hypoxic macrophages

@en

prefLabel

Advanced glycation end product ...... f Egr-1 in hypoxic macrophages

@ast

Advanced glycation end product ...... f Egr-1 in hypoxic macrophages

@en

P1433

Q34003967-95EE78A9-3A4A-4AAA-94C7-E72D50AC159A

P1476

Q34003967-1AD56E4A-F508-467C-AEC1-4F6B2A77B3BA

P2093

Q34003967-07ED27AD-B0BD-462A-A2D9-F874E715E860

Q34003967-0C89AF2B-E205-484C-9D09-D3AD8DD7B43D

Q34003967-9BDA2E17-A578-40B7-AB2D-28A4431D2832

Q34003967-A3DE9CE6-88D3-4F5A-B5E9-D923CDC73EF2

Q34003967-AA2749A1-5B3D-4CCD-934B-7CEF7E580EDA

Q34003967-BA2C7A31-FE18-4315-B366-6B7577FC4394

Q34003967-C315CBBD-7070-4B68-92A0-F9AE5968A74C

Q34003967-CD85BE0E-725D-45DF-B897-69F7D8BD800F

Q34003967-E242A032-2FEB-4F5D-9F45-5584F9DE18BA

Q34003967-FC6FD524-211F-47B1-86E1-EAE0CC204F44

P2860

Q34003967-0148658E-3965-4AD7-A30C-5871B8B31CD4

Q34003967-1B24B9D0-9BBF-4C7C-BD93-08FF1EA56962

Q34003967-22BD853A-9CDE-4D2E-8E99-632722111171

Q34003967-251F4E9D-2F93-4266-8CA5-F358B45647EB

Q34003967-356DA0AB-66C8-46F1-893A-C4037200B166

Q34003967-44175C2E-7791-487C-A38A-6F3D3B9BD3BC

Q34003967-50931387-E63F-4530-86EB-E4E844FDF0E3

Q34003967-515FEAFE-C87C-44C3-8C87-4189CEB8D6A0

Q34003967-55F6926B-54DB-453D-80EE-1CAC387228E2

Q34003967-5695BDD4-9735-4F3A-BE1A-D7394A5CE826

P304

Q34003967-51D0F992-37A1-4537-A58E-395E07D977C2

P31

Q34003967-38E138BD-B088-4789-AC63-04D7DBA9261F

P356

Q34003967-47AFF3F8-4F88-46DB-BADC-B927122E8FF1

P407

Q34003967-B9804640-8F9E-4A5A-8B7B-93F762CCDB5A

P433

Q34003967-114361A8-58C8-40BF-8165-532322103545

P478

Q34003967-69682313-F288-472C-8A7B-D9F67CCB919A

P577

Q34003967-CE511C69-47C8-44CE-8090-0046603296AC

P698

Q34003967-AF680587-18EE-4370-80F2-23C1955457CF

P921

Q34003967-74BD5B9F-6523-462B-AAFD-6F3F1FF3DA05

P932

Q34003967-4A93B9CD-8EB2-4949-B2F4-1C629FF6A7C4

P356

JBC.M110.117457

P1433

Journal of Biological Chemistry

P1476

Advanced glycation end product ...... f Egr-1 in hypoxic macrophages

@en

P2093

Ann Marie Schmidt

http://www.w3.org/2001/XMLSchema#string

Fatouma Toure

http://www.w3.org/2001/XMLSchema#string

Fei Song

http://www.w3.org/2001/XMLSchema#string

Joel Garcia

http://www.w3.org/2001/XMLSchema#string

Lili Lin

http://www.w3.org/2001/XMLSchema#string

Rosa Rosario

http://www.w3.org/2001/XMLSchema#string

Shi-Fang Yan

http://www.w3.org/2001/XMLSchema#string

Wu Qu

http://www.w3.org/2001/XMLSchema#string

Xiaoping Shen

http://www.w3.org/2001/XMLSchema#string

Yunlu Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)

Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation end products

Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice

Hypoxia/Hypoxemia-Induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis.

Macrophage roles following myocardial infarction

Macrophage responses to hypoxia: relevance to disease mechanisms.

P304

23233-23240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M110.117457

http://www.w3.org/2001/XMLSchema#string

P407

P433

30

http://www.w3.org/2001/XMLSchema#string

P478

285

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20507991

http://www.w3.org/2001/XMLSchema#string

P921

P932

2906316

http://www.w3.org/2001/XMLSchema#string